Kinase-dead PKB gene therapy combined with hyperthermia for human breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Gene Therapy

Background:

• Protein kinase B (PKB) is a key mediator of heat-induced apoptosis in human breast cancer cells.
• Abrogating PKB function holds therapeutic potential for breast cancer treatment.

Purpose of the Study:

• To investigate the therapeutic potential of inhibiting PKB function in human breast cancer cells.
• To evaluate the combined effect of a novel adenovirus expressing a kinase-inactive PKB gene (adv.AAA) and hyperthermia on cancer cell apoptosis and survival.

Main Methods:

• Construction of a replication-deficient adenovirus (adv.AAA) carrying a mutant, kinase-inactive PKB gene.
• Treatment of human breast cancer cell lines (MCF-7, MDA-468) and a normal mammary epithelial cell line (MCF-10) with adv.AAA and/or heat exposure.
• Assessment of apoptosis via apoptosis assays and clonogenic assays.
• Analysis of PKB and Forkhead phosphorylation and PKB kinase activity.

Main Results:

• Adv.AAA infection alone increased apoptosis, which was significantly enhanced by co-treatment with heat.
• MDA-468 cells showed greater sensitivity to adv.AAA and heat than MCF-7 cells; MCF-10 cells were most resistant.
• Clonogenic assays confirmed an additive interaction between adv.AAA and hyperthermia, with malignant cells being more sensitive.
• Adv.AAA therapy reduced PKB and Forkhead phosphorylation and inhibited PKB kinase activity, especially when combined with heat.

Conclusions:

• Inhibition of the PKB-dependent survival pathway promotes apoptosis and enhances thermosensitization in malignant breast cancer cells.
• The adv.AAA and hyperthermia combination demonstrates differential sensitivity, sparing normal mammary epithelial cells.
• This strategy suggests a potential therapeutic gain for breast cancer treatment by targeting PKB.